← All indications
Lymphatic Diseases
Diseases of LYMPH; LYMPH NODES; or LYMPHATIC VESSELS.
Subtype terms (14)
More specific conditions that are subtypes of Lymphatic Diseases in the MeSH hierarchy.
- Histiocytosis
23 drugs (15 approved, 8 experimental)
- Lymphadenitis
- Lymphadenopathy
16 drugs (14 approved, 2 experimental)
- Lymphangiectasis
- Lymphangitis
- Lymphatic Abnormalities
- Lymphedema
44 drugs (25 approved, 19 experimental)
- Lymphocele
3 drugs approved
- Lymphoproliferative Disorders
129 drugs (86 approved, 43 experimental)
- Mucocutaneous Lymph Node Syndrome
17 drugs approved
- Pseudolymphoma
- Splenic Diseases
- Thymus Hyperplasia
- Thymus Neoplasms
23 drugs (14 approved, 9 experimental)
Drugs by status
Approved for this indication (1)
Phase 4 trials (2)
Phase 3 trials (5)
Phase 2 trials (20)
Phase 1 trials (10)
Other trials (3)
Organizations
Organization Involved with Phase 2 Indications (9)
Organization Involved with Phase 1 Indications (5)
Organization Involved with Other Experimental Indications (3)